Equities

Zeria Pharmaceutical Co Ltd

4559:TYO

Zeria Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,132.00
  • Today's Change16.00 / 0.76%
  • Shares traded54.80k
  • 1 Year change-5.16%
  • Beta0.3357
Data delayed at least 20 minutes, as of Mar 29 2024 06:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zeria Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the development of ethical drug business, consumer healthcare business and other business. The Company operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

  • Revenue in JPY (TTM)74.57bn
  • Net income in JPY8.64bn
  • Incorporated1955
  • Employees1.73k
  • Location
    Zeria Pharmaceutical Co Ltd10-11, Nihombashi Kobuna-choCHUO-KU 103-8351JapanJPN
  • Phone+81 336632351
  • Fax+81 336632352
  • Websitehttps://www.zeria.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shin Nippon Biomedical Laboratories Ltd26.70bn5.50bn63.78bn1.21k11.592.118.752.39132.18132.18641.45725.030.41071.275.5522,105,960.008.469.4712.3014.3452.1950.0020.6024.390.9618--0.468723.0141.378.61-14.98--37.23--
Katakura Industries Co., Ltd.39.97bn3.05bn67.51bn1.02k20.870.846911.461.6991.8691.861,206.192,263.560.28792.264.70--2.332.353.053.3438.4537.758.098.322.57--0.110517.4416.62-2.048.0918.87-7.4610.76
ASKA Pharmaceutical Holdings Co Ltd62.03bn6.51bn67.54bn747.009.611.047.171.09230.05230.052,191.752,131.760.66821.723.4083,033,460.007.023.379.094.2548.1245.3910.505.021.96--0.143315.796.814.32-1.2112.16-13.152.71
Eiken Chemical Co Ltd39.90bn2.95bn78.68bn754.0024.931.4515.021.9778.8378.831,067.991,355.090.60132.743.0752,923,080.004.448.835.4511.3442.6746.397.3812.162.95--0.056331.240.63964.34-7.7517.070.621615.33
ispace Inc1.99bn-2.52bn79.15bn216.00--19.08--39.74-33.88-33.8824.7644.550.1476--24.879,219,852.00-18.66---32.11--46.91---126.42--1.72-16.860.7317--46.74---180.75------
JCR Pharmaceuticals Co Ltd41.37bn5.36bn111.01bn879.0020.011.9213.552.6842.7842.78330.47445.940.42530.54923.0347,059,160.005.539.638.3814.6774.8374.3412.9919.321.1519.240.29427.35-32.7710.77-74.004.2053.6725.21
Zeria Pharmaceutical Co Ltd74.57bn8.64bn112.40bn1.73k10.801.197.221.51195.97195.971,691.651,780.160.5141.443.3743,130,530.005.963.379.315.4073.9071.4511.606.520.8269--0.391541.3314.871.1556.418.305.403.30
Takara Bio Inc47.67bn1.57bn117.28bn1.79k74.661.0417.892.4613.0513.05395.88932.120.37951.472.5826,586,730.001.2711.781.3813.3655.3263.903.3420.225.81--0.0024.1315.4319.32-19.3346.9729.8756.32
Kyorin Pharmaceutical Co Ltd119.83bn4.26bn117.39bn2.14k24.480.824713.860.979774.2374.232,089.342,203.280.6781.342.7356,047,710.002.413.203.123.9342.9248.723.565.101.40--0.14170.577.330.47120.12-6.4019.42-2.16
Torii Pharmaceutical Co Ltd54.64bn4.12bn118.51bn583.0028.080.962725.882.17146.56146.561,944.214,274.440.40913.032.1393,718,700.003.086.523.417.3545.3749.557.5417.986.19--0.00224.1711.74-2.674.4428.76-20.3820.11
Mochida Pharmaceutical Co Ltd100.09bn3.01bn119.72bn1.53k37.880.892520.761.2084.3484.342,768.283,579.890.62941.862.9165,457,820.001.894.862.265.9451.2452.203.017.363.24--0.0041.96-6.28-0.6644-37.09-5.9214.62-1.21
Sosei Group Corp12.77bn-7.19bn144.99bn350.00--2.17--11.36-87.73-87.73154.90746.930.0995--3.3936,474,280.00-5.61-0.6588-6.11-0.703675.7089.83-56.34-4.463.62-8.250.5254---18.00---1,982.98------
GNI Group Ltd26.01bn8.09bn149.87bn701.0018.774.4314.825.76160.06160.06531.67678.010.54021.787.33--19.747.2322.658.7886.2485.7536.5414.573.6726.420.09310.0049.3238.971,981.71--19.69--
Towa Pharmaceutical Co Ltd236.78bn11.74bn150.94bn4.30k12.290.9694.720.6375238.42238.424,810.523,023.620.61341.623.7355,090,510.003.044.733.806.3934.6641.274.968.061.48--0.568619.9726.1117.46-86.17-19.4614.6613.63
KAKEN PHARMACEUTICAL CO., LTD.72.10bn2.97bn156.93bn1.13k43.720.923127.452.1878.1478.141,915.493,700.490.4291.862.8963,801,770.001.768.172.009.5653.8955.554.1116.094.68--0.026744.04-4.01-5.81-43.03-22.173.160.00
Sumitomo Pharma Co Ltd330.31bn-173.72bn157.57bn6.25k--0.4579--0.477-437.26-437.26831.40864.730.27171.362.7152,849,120.00-14.951.15-22.201.6759.9372.18-55.042.540.3785--0.545241.44-0.80193.54-232.08--0.62043.13
Data as of Mar 29 2024. Currency figures normalised to Zeria Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

8.62%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 29 Feb 20241.23m2.32%
Nomura Asset Management Co., Ltd.as of 29 Feb 2024849.60k1.60%
Asset Management One Co., Ltd.as of 15 Sep 2022677.10k1.28%
Nikko Asset Management Co., Ltd.as of 08 Mar 2024395.70k0.75%
Daiwa Asset Management Co. Ltd.as of 29 Feb 2024386.70k0.73%
Norges Bank Investment Managementas of 31 Dec 2023345.30k0.65%
Dimensional Fund Advisors LPas of 07 Mar 2024219.70k0.41%
Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Mar 2024169.20k0.32%
BlackRock Fund Advisorsas of 07 Mar 2024162.50k0.31%
Mellon Investments Corp.as of 07 Mar 2024144.00k0.27%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.